Timothy J. Sangiovanni insider trades: Zevra Therapeutics (ZVRA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Timothy reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 3, 2026 | ZVRA | ↓ Sell | 3,000 | $9.18 | $28K | Direct | Feb 4, 2026 (1d) |
| Feb 13, 2025 | ZVRA | ↓ Sell | 3,000 | $7.86 | $24K | Direct | Feb 14, 2025 (1d) |
| Mar 10, 2023 | ZVRA | ↑ Buy | 1,200 | $4.14 | $5K | Direct | Mar 13, 2023 (3d) |
| Mar 13, 2020 | KMPH | ↑ Buy | 4,000 | $0.20 | $800 | Direct | Mar 16, 2020 (3d) |
| Mar 10, 2020 | KMPH | ↑ Buy | 8,000 | $0.25 | $2K | Direct | Mar 10, 2020 (0d) |
| Sep 24, 2019 | KMPH | ↑ Buy | 3,000 | $0.74 | $2K | Direct | Sep 25, 2019 (1d) |
| Oct 12, 2018 | KMPH | ↑ Buy | 3,000 | $2.52 | $8K | Direct | Oct 15, 2018 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ZVRA insiders
Open-market trades in the last 12 months
About Timothy J. Sangiovanni's insider trades
Timothy J. Sangiovanni is SVP, Finance & Corp Controller at Zevra Therapeutics (ZVRA). Since Oct 12, 2018, Timothy has reported 5 open-market purchases worth $18K and 2 sales worth $51K on SEC Form 4. In the last 12 months: 1 sale ($28K).
Their filings also include grants and awards (10 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ZVRA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.